Comparative Pharmacology
Head-to-head clinical analysis: DELFLEX W DEXTROSE 1 5 IN PLASTIC CONTAINER versus DELFLEX W DEXTROSE 1 5 LOW MAGNESIUM LOW CALCIUM IN PLASTIC CONTAINER.
Peer-Reviewed Evidence
Head-to-head clinical analysis: DELFLEX W DEXTROSE 1 5 IN PLASTIC CONTAINER versus DELFLEX W DEXTROSE 1 5 LOW MAGNESIUM LOW CALCIUM IN PLASTIC CONTAINER.
DELFLEX W/ DEXTROSE 1.5% IN PLASTIC CONTAINER vs DELFLEX W/ DEXTROSE 1.5% LOW MAGNESIUM LOW CALCIUM IN PLASTIC CONTAINER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Delflex (icodextrin) is an iso-osmotic, high molecular weight glucose polymer that acts as a colloid osmotic agent in peritoneal dialysis. It induces ultrafiltration across the peritoneal membrane by creating an osmotic gradient, removing excess fluid and uremic toxins from the blood.
Peritoneal dialysis solution; dextrose provides osmotic gradient for ultrafiltration; electrolytes correct imbalances; low magnesium and calcium adjust levels in renal failure.
Intraperitoneal administration: 2 liters per exchange, 4 exchanges per day (total 8 L/day). Exchange volumes typically 2-2.5 L per exchange, dwell time 4-6 hours.
Intraperitoneal administration: 2 liters per exchange, 4 exchanges per day, or 8-10 liters over 10-12 hours for overnight cycler, with dextrose concentration selected based on ultrafiltration needs.
None Documented
None Documented
Not applicable; the solution acts locally in the peritoneal cavity. For absorbed dextrose, plasma glucose disappearance half-life is approximately 1-2 hours in patients with normal insulin response. In diabetic patients, half-life may be prolonged.
Not applicable as a terminal half-life for the solution itself; glucose absorption half-life from peritoneal cavity is approximately 2-4 hours, reflecting peritoneal clearance. There is no systemic accumulation of the solution's components beyond expected glucose metabolism.
Peritoneal dialysis fluid components: Delflex solutions are not absorbed systemically in significant amounts. The small amount of glucose absorbed (approx. 10-30% of instilled dose depending on dwell time and dextrose concentration) is metabolized via normal pathways. Water and electrolytes are removed via peritoneal dialysis. No renal or biliary excretion of the solution itself; glucose metabolites are excreted renally (CO2 and H2O).
Primarily eliminated via peritoneal drainage during continuous ambulatory peritoneal dialysis (CAPD). Approximately 60-80% of glucose is absorbed across the peritoneum and metabolized systemically; non-metabolized glucose and other solutes are removed in dialysate effluent. Renal excretion is negligible (<5%) in patients with end-stage renal disease on CAPD.
Category C
Category C
Peritoneal dialysis solution
Peritoneal dialysis solution